Articles

Results 1 to 5 of 33


Implementation of “Countering Foreign Influence Program” for Scientific Research Funded by DARPA

USA - March 18 2022 Over the past three years, the U.S. Congress has directed the Defense Advanced Research Projects Agency (“DARPA”), the research and development…

Christina A. Ravelo, Kyle S. Shaub

DOJ Increases Focus on Clinical Trial Fraud

USA - February 1 2022 While speaking at the Food & Drug Law Institute’s Enforcement, Litigation and Compliance Conference in December, Deputy Assistant Attorney General…

Samantha Barrett Badlam, Andrew O'Connor, Kyle S. Shaub, Beth P. Weinman

New SACHRP Recommendations on Interactions among Sponsors, Clinical Trial Sites, and Study Subjects

USA - May 5 2021 The U.S. Department of Health and Human Services Secretary’s Advisory Committee on Human Research Protections (“SACHRP”) recently issued…

David Peloquin

State Department Asks University Boards to Divest Holdings in the People’s Republic of China (PRC) and Prevent “Foreign Influence” on University Programs

China, USA - August 20 2020 On Tuesday, August 18, 2020, the Under Secretary of State for Economic Growth, Energy and the Environment, Keith Krach, released a letter to the…

Senate Introduces the “Safeguarding American Innovation Act,” Targeting Foreign Influence and Unreported Foreign Ties in Research

USA - June 24 2020 Last Thursday, June 18, a long-awaited, bipartisan bill to address the federal government's concerns about "foreign influence" in research, the…

Valerie H. Bonham, Matthew Colin, Richard A. Harris, II, Elizabeth King, Gideon Zvi Palte, Christina A. Ravelo